US budget office extends deadline for input on domestic drug manufacturing capacity to November 27
The Office of Management and Budget has reopened its request for information on drug manufacturing capacity in the United States and nearby countries. The original 30-day window closed on October 26, 2026, and responses are now accepted until November 27, 2026. The request covers factories that are new or currently idle, and the extra time is meant to let interested parties prepare their answers.
This summary was generated by AI; the official source prevails.
What does it mean?
The government is asking companies and others for details on factories that could make medicines in the U.S. or nearby countries. You now have until November 27, 2026 to send in your response.
Who is affected?
Drug makers, factory owners, and other parties who could supply essential medicines or their ingredients.
What changes?
Previously the response deadline was October 26, 2026; now it is November 27, 2026.